Necessary risks.
D000818:Animals; D000932:Antiemetics / Q000009:adverse effects*; D004285:Dogs; D013759:Dronabinol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009369:Neoplasms / Q000188:drug therapy*; D011247:Pregnancy; D011346:Prochlorperazine / Q000627:therapeutic use; D012306:Risk; D013792:Thalidomide / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D000932:Antiemetics; D013792:Thalidomide; D013759:Dronabinol; D011346:Prochlorperazine